PARK7/DJ1 Antikörper (N-Term)
Kurzübersicht für PARK7/DJ1 Antikörper (N-Term) (ABIN2330398)
Target
Alle PARK7/DJ1 (PARK7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- PARK7, NT (Protein DJ-1, Oncogene DJ1, Parkinson Disease Protein 7)
-
Aufreinigung
- Purified by ammonium sulfate precipitation.
-
Immunogen
- Synthetic peptide selected from the N-terminal region of human Park7 (DJ-1) (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))
-
Andere Bezeichnung
- PARK7
-
NCBI Accession
- NP_009193
-
UniProt
- Q99497
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Proton Transport
Target
-